Abstract:Objective To investigate the effect of miR-132-3p on the proliferation of endothelial progenitor cells and its regulatory mechanism in order to provide a new theoretical basis for the treatment of deep venous thrombosis. Methods Real-time quantitative PCR (qPCR) was used to detect the expression of miR-132-3p in the plasma and endothelial progenitor cells of 27 healthy volunteers and 22 thrombus patients, and in endothelial progenitor cells under normoxic and hypoxic conditions. The miR-132-3p analogue and the specific siRNA were transferred into endothelial progenitor cells by the electroporation method. The effect of miR-132-3p on the proliferation of endothelial progenitor cells was detected using MMT and Cell Counting Kit-8 (CCK-8) methods. The effects of miR-132-3p on the expression of FOXO1 in endothelial cells were analyzed using the luciferase assay and western blots. Results The expression of miR-132-3p in clinical patients with thrombosis was significantly decreased to 0.45 ± 0.05 times of that of the healthy volunteers (P＜0.05). The expression of miR-132-3p in endothelial progenitor cells under hypoxia was down-regulated to (0.23 ± 0.13) times of that of under normoxia (P＜0.05). The expression of miR-132-3p of experiment group under hypoxia was up-regulated to (15.72 ± 2.06) times of that of control group (P＜0.05). MMT assay showed that the proliferation of cells in the experimental group under hypoxic condition was up-regulated to (7.79 ± 1.37) times of that in the control group (P＜0.01). CCK-8 assay showed that cell proliferation in experimental group was up-regulated to (6.46 ± 0.38) times of that in the control group (P＜0.01). Software analysis showed that FOXO1 was a direct target of miR-132-3p. Luciferase activity of miR-132-3p mimics transfected endothelial progenitor cells under hypoxic conditions were 0.47 times of that in siRNA treatment group. Western blot showed that the expression of FOXO1 protein in endothelial progenitor cells transfected with miR-132-3p mimics in hypoxia was 0.18 times of that in siRNA treatment group. Conclusions Compared with healthy volunteers, miR-132-3p expression in the blood of patients with thrombosis was significantly reduced that can promote transcription of the FOXO1 gene (and protein expression) and inhibit the proliferation of endothelial progenitor cells. It could be closely related to the formation of venous thrombosis.

Micrornas Regulate Nitric Oxide Release from Endothelial Cells by Targeting NOS3

Role of Specific Micrornas for Endothelial Function and Angiogenesis

Upregulation of Mir-483-3p Contributes to Endothelial Progenitor Cells Dysfunction in Deep Vein Thrombosis Patients Via SRF.

Abstract P640: Endogenous Micrornas in Human Microvascular Endothelial Cells Regulate Mrnas Encoded by Hypertension-Related Genes and Are Functionally Important

Shear stress regulation of miR-93 and miR-484 maturation through nucleolin.

Essential Role of MicroRNA-155 in Regulating Endothelium-Dependent Vasorelaxation by Targeting Endothelial Nitric Oxide Synthase

MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis

Commutative regulation between endothelial NO synthase and insulin receptor substrate 2 by microRNAs.

Role and Mechanism of Mir-5189-3p in Deep Vein Thrombosis of Lower Extremities

Abstract 162: MicroRNAs Mediate the Hemodynamic Regulation of Endothelium-to-Smooth Muscle Signaling

Downregulation of Interleukin-6 and C-reactive Protein Underlies a Novel Inhibitory Role of Microrna-136-5p in Acute Lower Extremity Deep Vein Thrombosis

MiR-132-3p regulates proliferation of endothelial progenitor cells mediated by FOXO1

Downregulation of Mir-125A-5p Promotes Endothelial Progenitor Cell Migration and Angiogenesis and Alleviates Deep Vein Thrombosis in Mice Via Upregulation of MCL-1.

Retracted: Effects of Microrna‐330 on Vulnerable Atherosclerotic Plaques Formation and Vascular Endothelial Cell Proliferation Through the WNT Signaling Pathway in Acute Coronary Syndrome

A Panel of Micrornas As a New Biomarkers for the Detection of Deep Vein Thrombosis

Advances in microRNA regulation of deep vein thrombosis through venous vascular endothelial cells (Review)

Mir-22-3p Inhibits Arterial Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia by Targeting HMGB1 in Arteriosclerosis Obliterans.

Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition

MiR-128-3p promotes the progression of deep venous thrombosis through binding SIRT1

MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells

Mir-21 Induces Endothelial Progenitor Cells Proliferation and Angiogenesis Via Targeting FASLG and is a Potential Prognostic Marker in Deep Venous Thrombosis